Deson Development International Holdings Limited Overview
Deson Development is a Hong Kong-headquartered, Bermuda-incorporated micro-cap whose economic centre of gravity is a single tier-3 city: Kaifeng, Henan Province, an ancient Song dynasty capital. Founded in 1988 as a building contractor, it spun off its construction arm in 2015. It then wound down its Hainan property exposure in 2023, and is now pivoting from selling residual apartments, shops and villas toward owning and operating franchised hotels. It operates four branded hotels in Kaifeng under IHG (Holiday Inn Express), H World (Orange Hotel, Hi Inn) and Atour, totalling 504 rooms. It retains a HK$634 million investment-property book in Kaifeng and a small but steady Hong Kong trading business supplying hydrotherapy and rehabilitation equipment to public healthcare buyers. The investment case is a deep-discount asset play: shares trade at roughly 0.1x book value. Against that, the group has made losses in each of the last six years, and its PRC asset values are still being written down.
Company's own description (latest annual report / results announcement)
In its FY2026 filings the group describes three principal activities. The first is property development and investment: developing residential and commercial properties in the PRC and holding investment properties. The second is trading of medical equipment and home security and automation products, including related installation. The third is the operation of hotels (FY2026 Results Announcement, Note 1 and MD&A). The FY2026 annual report, as summarised by MiniChart (23 Jul 2026), frames the group as moving assets from property sales into hotel operations to build recurring income. It also stresses green hotel operations and a "manachised" (management plus franchise) hotel model.
Independent characterisation
In substance, Deson Development is a residual-asset monetisation vehicle with an emerging hotel-ownership business, attached to a small Hong Kong healthcare-equipment distributor.
- Property development and investment (FY2026: 32.7% of revenue). This is no longer an active development business in the conventional sense. The group has not acquired new land since February 2012. It is selling down completed inventory at two Kaifeng projects, Century Place (~210,500 sq.m. GFA) and World Expo (~95,000 sq.m. GFA), and leases investment-property shops. Inventory (properties held for sale) has fallen from HK$784.7m (Mar-2022) to HK$299.1m (Mar-2026). Part of that decline reflects reclassification of unsold space into hotel use rather than sales.
Hotel operations (FY2026: 32.4%): This is a franchised and managed model. The group owns or leases the real estate, funds fit-out to brand standards, and bears operating costs. Brand partners (IHG, H World, Atour) supply brand, reservation systems and on-site management for fees. The group therefore takes full operating leverage and asset risk; this is not an asset-light fee model.
Trading (FY2026: 35.0%): This is a project-based distribution business in Hong Kong. It supplies hydrotherapy pools, rehabilitation equipment, air purifiers and wellness products, plus a declining home security and automation line. Customers are concentrated in the public sector: the Hospital Authority, the Correctional Services Department, universities and NGOs such as the Hong Kong PHAB Association.
Revenue model mix
| Revenue type | FY2026 | % of total | Nature |
|---|---|---|---|
| Sale of properties (point in time) | 29,838 | 24.5% | Product / transactional |
| Gross rental income from investment properties | 9,911 | 8.1% | Recurring lease income |
| Trading of medical equipment, home security and automation | 42,545 | 35.0% | Product plus installation services, project-based |
| Hotel operations – rooms (over time) | 34,330 | 28.2% | Service, recurring |
| Hotel operations – F&B and retail (point in time) | 5,060 | 4.2% | Service / product |
| Total | 121,684 | 100% | — |
Source: FY2026 Results Announcement, Note 4: There is no subscription or licensing revenue. Recurring revenue (rental plus hotel rooms) was about 36% of FY2026 revenue, versus roughly 26% in FY2025.
Value chain position, customers, end-markets
| Dimension | Property | Hotels | Trading |
|---|---|---|---|
| Value-chain position | Landowner and developer (construction outsourced); landlord | Asset owner/lessee and franchisee; brand partners manage | Importer/distributor and installer (EWAC Medical-type rehab equipment, PPP air purifiers) |
| Customer types | Retail homebuyers and investors in Kaifeng; commercial tenants (e.g., a hotel operator leasing 6,200 sq.m. in Section F) | Domestic leisure tourists visiting Kaifeng's Song City zone; business travellers | Hong Kong public hospitals (Hospital Authority clusters), government departments, universities, NGOs, elderly-care operators |
| End-market | Tier-3 PRC residential and commercial real estate | PRC domestic cultural tourism (Central Plains) | Hong Kong rehabilitation and healthcare equipment; security and video analytics |
| Major customer concentration | FY2025: one property buyer = HK$36.9m (27% of group revenue) | Fragmented | FY2026: one medical-equipment customer = HK$13.3m (11% of group revenue) |
Sources: FY2026 Results Announcement, Note 3 "Information about major customers"; FY2022 Results Announcement prospects section.
Strategy
Stated strategic themes (paraphrased from FY2024–FY2026 filings)
-
Pivot from property sales to recurring hotel income. Unsold or slow-moving Kaifeng space is converted into branded hotels, and new hotel premises are leased, under franchise and "manachised" agreements with major PRC and international hotel groups (FY2026 annual report as summarised by MiniChart; FY2026 Results Announcement).
-
Capitalise on Kaifeng cultural tourism. Management cites rising visitor arrivals linked to Song dynasty heritage attractions as the core demand driver for hotels.
-
Monetise residual property inventory and lease out unsold space to reliable tenants for rental income (FY2024 Prospects).
-
Grow Hong Kong healthcare-equipment trading on the back of population ageing and hospital capital projects, and broaden product range and channels.
-
Promote AI video analytics and smart-city solutions through the Axxonsoft HK associate.
-
Cost control and tight credit control, plus governance, risk management and asset-management capability-building (recurring language across FY2022–FY2026).
-
ESG themes in hotel operations: green hotel operations, modular construction, renewable energy and digital resource management (FY2026 annual report per MiniChart).
The FY2022 annual results set out four objectives for the rest of 2022: (i) recycle capital by buying quality Hong Kong properties at attractive prices and selling mature ones; (ii) improve efficiency and reduce expenses; (iii) gear up projects responsibly to raise ROE; (iv) expand medical and security trading. In hindsight, (i) and (iii) were not pursued. The group instead deleveraged and exited non-core investments.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Orange Hotel launch | Oct 2024 | 89 rooms; H World franchise; built on 8 leased and 1 owned four-storey houses at Longting Lake Xiyuan; 15-year leases (Jul 2024 – Jun 2039), ROU asset ~RMB29.2m | Operating; 91% occupancy FY2026 |
| Hi Inn launch | Jun 2025 | 60 rooms; H World economy franchise; 1,900 sq.m. of Century Place Section F | Operating; 79% occupancy |
| Atour Hotel launch | Sep 2025 | 112 rooms; 10 villa buildings (Century Place Section C, former unsold villas) | Operating; 80% occupancy |
| Collection of Haikou disposal consideration | Oct 2024 – Jun 2027 | RMB120m (31 Oct 2024), RMB110m (1 Dec 2025), RMB30m (due 30 Jun 2026), RMB25m (due 30 Jun 2027). RMB40m of the last RMB55m received by June 2026 | On track |
| Debt reduction | FY2025–FY2026 | Gross debt down from HK$366m to HK$99m; 15M bond repaid | Completed |
| Disposal of non-core subsidiaries | Apr and Sep 2024 | Tian Tong Satellite; Treasury Field | Completed |
| Healthcare project pipeline | FY2026 | PHAB hydrotherapy pool (~HK$7.8m); targeting Kai Tak Hospital and other Hospital Authority expansions | Ongoing |
Medium-term targets and guidance
No quantitative financial targets or guidance have been published. There is no revenue, margin, RevPAR or hotel-count target. Management's outlook is qualitative. Its view is that Kaifeng property is a buyer's market, with returns likely limited for the next 1–2 years. It describes the hotel outlook as stable, with headwinds from staffing shortages and rising costs, and expects steady, resilient demand for Hong Kong rehabilitation equipment in 2026 (FY2026 Results Announcement, Prospects).
Products & Services
Property development and investment — Century Place, Kaifeng
| Section | Current use | Unsold / retained GFA (31 Mar 2026) |
|---|---|---|
| A | Investment properties – shops (leased out) | 53,600 sq.m. |
| B | Held for sale – apartments; car parks | 200 sq.m.; 70 units |
| C | Property, plant & equipment – Atour Hotel (former villas) | 4,800 sq.m. |
| D | Held for sale – offices; car parks | 1,200 sq.m.; 10 units |
| E | Held for sale – shops | 350 sq.m. |
| F | Held for sale – shops; investment property – hotel leased out; PP&E – Hi Inn; car parks | 3,000 sq.m.; 6,200 sq.m.; 1,900 sq.m.; 80 units |
| G ("璽園, No.1 Longting Lake") | Held for sale – apartments and shops; PP&E – Orange Hotel; car parks | 8,100 sq.m.; 1,300 sq.m.; 1,900 sq.m.; 88 units |
Description: Residential and commercial complex in Long Ting District, Kaifeng. Land was granted 9 June 2005. Total GFA ~210,500 sq.m., all construction completed. Cumulative contract sales: ~RMB792m for Sections A–F and ~RMB133m for Section G.
Target customer: Kaifeng owner-occupiers and investors; commercial and hotel tenants.
Pricing: Not publicly disclosed. FY2022 and FY2024 filings record significant unit-price declines for unsold villas in Zones C and F.
Source: FY2026 Results Announcement, Prospects. The FY2022 annual report describes Section G as lakeside commercial townhouses (villas) and deluxe apartments of 20,500 sq.m. GFA.
Property development and investment — World Expo, Kaifeng
| Component | Current use | GFA (31 Mar 2026) |
|---|---|---|
| Commercial Section A | PP&E – Holiday Inn Express | 14,000 sq.m. |
| Commercial Section B | Held for sale – shops | 2,300 sq.m. |
| Residential Blocks 1–3 | Held for sale – apartments | 5,900 sq.m. |
| Car parks | Held for sale | 142 units |
Description: Residential and commercial complex, ~95,000 sq.m. GFA. Land won 16 February 2012. Cumulative contract sales ~RMB574m. The largest single sale was the old animation centre (5,823 sq.m.) for RMB34m in FY2024, at a gross margin of only about 17%.
Property investments outside Kaifeng (current and recently exited)
| Asset | Status | Detail |
|---|---|---|
| Haikou commercial properties ("Asian Villas" retail space) | Exited 30 Aug 2023 | Sold to Haikou Longhua City Investment Holding for RMB385m. RMB15m of the consideration remained outstanding at June 2026. |
| Excel Castle International (10% equity, FVTPL) | Held (latest carrying value not separately disclosed in FY2026 announcement) | Hong Kong investment holding vehicle redeveloping a Tsim Sha Tsui commercial building; completion was targeted for 2026. Cost ~HK$80m; carrying value HK$40.0m at Mar-2022 |
| Pamfleet Shanghai Real Estate Fund II (1.5% LP) and Pamfleet China GP II (30%) | Fund interest disposed in FY2025 | Value-add Shanghai office ("Project Hub", 37,547 sq.m., Jing'an) |
| Project Parkview / Cohost West Bund (30% associate) | Exited FY2022 | Sold for RMB197m |
Hotel portfolio (all Kaifeng, PRC)
| Hotel | Brand owner / operator | Opened | Rooms | GFA | Positioning | FY2026 revenue (HKD Mn) | FY2026 occupancy | FY2026 ADR (MYR Bn) | FY2026 RevPAR (MYR Bn) |
|---|---|---|---|---|---|---|---|---|---|
| Holiday Inn Express Kaifeng City Center | IHG (InterContinental Hotels Group (Shanghai)) | Jan 2020 | 243 (incl. 1 suite) + 3 meeting rooms (~460 sq.m.) | ~14,000 sq.m. | International select-service, city centre | 14.2 | 45% | 221 | 116 |
| Orange Hotel | H World Group (franchise) | Oct 2024 | 89 | ~4,700 sq.m. | Mid-scale; lake-view rooms next to Longting Lake in Song City tourist zone | 13.0 | 91% | 381 | 377 |
| Hi Inn Kaifeng Millennium City Park | H World Group (franchise) | Jun 2025 | 60 | ~1,900 sq.m. | Fully self-service economy | 3.4 | 79% | 209 | 169 |
| Atour Hotel | Atour Lifestyle Holdings | Sep 2025 | 112 (incl. 10 suites) | ~6,000 sq.m. (10 villa buildings) | Upper-midscale lifestyle | 8.8 | 80% | 462 | 396 |
Source: FY2026 Results Announcement, Hotel operations section. FY2025 comparatives: Holiday Inn occupancy 43%, ADR RMB221, RevPAR RMB115, revenue HK$14.4m; Orange Hotel (six months) occupancy 86%, ADR RMB315, RevPAR RMB314, revenue HK$4.7m.
Analyst observation. The three tourist-zone hotels (Orange, Hi Inn, Atour) achieve occupancy of 79–91% and RevPAR of RMB169–396. The legacy city-centre Holiday Inn Express runs at 45% occupancy and RevPAR of RMB116, and its F&B and retail revenue is falling. Location within the Song City tourist zone is evidently the key value driver. That makes Holiday Inn the obvious candidate for repositioning or disposal.
Trading — medical equipment and wellness
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Hydrotherapy pools and aquatic rehabilitation | Design, supply, installation, testing and commissioning of hydrotherapy treatment pools | Hospital Authority hospitals (e.g., United Christian Hospital), NGOs | FY2026: ~HK$7.8m nominated sub-contractor order for the Hong Kong PHAB Association multi-function services centre. HK$3.8m receivable on United Christian Hospital pools impaired after being outstanding for more than a year. |
| Rehabilitation equipment | Physiotherapy and geriatric rehab devices | Public hospitals, private clinics, elderly centres | Management expects demand from population ageing and hospital projects, citing Kai Tak Hospital, Princess Margaret Hospital (Lai King Building) and United Christian Hospital |
| PPP medical-grade air purifiers | Group was sole Hong Kong distributor (FY2022). Model PPP-1200-01 AD designed for hospitals, with multi-inlet and outlet; company states FDA and AHAM certification | Hospitals, universities, prisons, elderly centres | Drove FY2022 peak trading revenue (HK$69.6m); demand faded after COVID |
| Wellness and pandemic-prevention products | Consumables and devices | Institutions | Dedicated subsidiary set up in FY2022 |
| Taiwan distribution (via 35% associate UltraX Technologies) | Holds Taiwan retail and wholesale medical equipment licence and EWAC Medical aquatic rehab distribution rights | Taiwan hospitals | Associate; not consolidated |
| Digital rehab platform (via 20% associate Hope4Care) | AR/VR rehabilitation training for stroke survivors and the elderly (upper limb, lower limb, balance) | Elderly and chronic patients | ISO 13485 granted (FY2024); HK$1.1m grant under the CUHK Technology Start-up Support Scheme for Universities 2024–25 |
Trading — home security and automation
| Product line | Description | Notes |
|---|---|---|
| AI video analytics (via associate Axxonsoft Hong Kong) | Loitering detection, people-flow analysis, posture and behaviour analysis, epidemic-control support | Provides people-flow analytics to financial institutions and video management platforms to Hong Kong government bodies |
| Smart-city integration | Solutions for malls, government facilities, border points and airports | FY2024: a large mainland airport project integrating access control, intrusion and fire alarms with over 18,000 video channels. Mainland security trading was later terminated (FY2024). |
| Home security and automation products | Product supply and installation in Hong Kong | Revenue down from HK$14.5m (FY2021) to HK$2.3m (FY2026) |
Discontinued or immaterial lines
Construction contracting was spun off in 2015. Deson Metals (construction materials trading, 60%) was acquired in FY2023 with its goodwill fully impaired. Tian Tong Satellite Communication (51%) was sold on 10 April 2024 for HK$51,000. Treasury Field Investments was sold on 30 September 2024, 15% each to Mr. Tjia and Mr. Wang and 70% to third parties.
Financial Narrative
All figures HK$ million, fiscal years ended 31 March. Sources: FY2022 Results Announcement (FY2022), FY2024 Results Announcement (FY2023, FY2024), FY2026 Results Announcement (FY2025, FY2026). Rows marked "derived" are analyst calculations from reported figures.
Income statement
Note on FY2022: In the FY2022 statutory format, "other operating income, net" of +HK$39.4m included a +HK$110.2m FVTPL gain. That gain is shown on its own line above, so the residual other operating expense for FY2022 is −HK$70.8m. The residual includes the HK$41.9m NRV provision and the HK$19.4m hotel revaluation deficit. FY2024 disposal gains: HK$31.0m on disposal of a subsidiary plus HK$41.6m on disposal of investment properties (Haikou). Core loss: management's figure excluding non-recurring items and fair-value adjustments (FY2026 Results Announcement). Excluding hotel decoration depreciation as well, management's core loss falls to HK$25.8m (FY2025: HK$35.3m).
Margins (analyst-derived)
Revenue CAGR (FY2022–FY2026, derived): +2.6% per year (HK$110.0m to HK$121.7m). From the FY2021 base (HK$103.8m) the five-year CAGR is +3.2%.
Commentary. Revenue has oscillated within a narrow HK$98–135m band. Underneath, the mix has changed almost completely: from COVID-driven air-purifier trading (FY2022), to lumpy property sell-down (FY2024–FY2025), to hotels and trading (FY2026). Gross margin is set by mix rather than pricing power. Rental income carries margins above 90% (FY2022 MD&A), so the rent collapse in FY2026 is especially damaging at the gross-profit level. Hotel growth offset it, lifting gross margin to 45%.
The structural problem is overhead. Administrative expenses of HK$94.6m in FY2026 exceeded gross profit by HK$40m. The FY2026 increase was driven partly by depreciation and pre-opening costs for two new hotels. Every year shows a reported loss. The swing factors are non-cash and non-operating:
-
fair-value movements on investment properties (cumulative −HK$115.7m over FY2022–FY2026);
-
fair-value movements on listed and unlisted equity investments (cumulative −HK$91.5m);
-
one-off disposal gains (FY2024: +HK$72.7m plus a HK$74.9m dividend).
The one consistently positive trend is finance costs, which fell from HK$36.7m (FY2023) to HK$12.1m (FY2026) as Haikou disposal proceeds deleveraged the balance sheet.
Balance sheet
Debt composition notes: FY2023 long-term debt = HK$170.0m bank and other borrowings + HK$33.0m bonds + HK$51.3m related-party loan. FY2024 short-term debt = HK$235.1m bank and other + HK$33.0m bonds + HK$37.8m related-party loan. FY2025 long-term debt = HK$42.6m bank and other + HK$15.0m bond. The 15M bond was repaid in full during FY2026. Pledged assets: HK$1,008.5m (FY2022), HK$759.7m (FY2024), HK$338.9m (FY2026).
Commentary. The balance sheet has shrunk by 36% in four years, from HK$2.47bn to HK$1.58bn. The drivers were disposals (Haikou), sell-down of inventory, exit from equity investments, and cumulative fair-value and FX losses. Equity attributable to owners fell from HK$1.68bn to HK$1.23bn. FY2026 total comprehensive loss was only HK$23.0m, because RMB appreciation produced a +HK$58.5m translation gain. This highlights that reported NAV is materially sensitive to the RMB/HKD rate, since 91% of non-current assets sit in mainland China.
The key positive is deleveraging. Gross debt (excluding leases) fell from HK$476.5m (FY2023) to HK$98.7m (FY2026), and company-reported net gearing fell from 31% to 9%. The key watch-point is liquidity. Cash is only HK$31.4m against HK$86.7m of short-term borrowings, and the remaining Haikou receivable (RMB15m) is nearly exhausted. Net current assets of HK$213m are dominated by HK$299m of slow-moving Kaifeng inventory.
Cash flow
Operating cash flow and free cash flow: not publicly disclosed in the results announcements reviewed. Qualitatively, the decline in gross debt of ~HK$378m over FY2023–FY2026 was funded mainly by Haikou disposal proceeds and the equity-investment exit, not by operating cash flow.
-
FY2024 cash inflows recorded on the Haikou disposals were HK$51.2m (Disposal 2) and HK$11.6m (Disposal 1) at completion, plus deposits received earlier (FY2024 Results Announcement, Notes 15 and 17).
-
FY2025–FY2026 capex reflects right-of-use assets and leasehold improvements for the Orange Hotel, Hi Inn and Atour (FY2026 Results Announcement).
Ratios (analyst-derived unless stated)
Net debt/EBITDA is not meaningful because EBITDA is negative in every year (blank cells). Interest coverage is negative (operating losses), so the company does not cover interest from operations. Cash conversion cycle is not meaningful for a developer and hotel owner; inventory days on property stock are measured in years. Blank cells are intentional.
Commentary on ratios. Returns are persistently negative at −5% to −7% of equity. Because the stock trades at roughly 0.1x book, the market is effectively capitalising expected continued value erosion. Asset turnover is extraordinarily low at 0.07x: HK$1.6bn of assets generate HK$122m of revenue. The core thesis question is whether the hotel pivot can raise asset turnover materially. Leverage ratios have improved sharply and are no longer the binding constraint. The binding constraint is now operating profitability and liquidity.
Interim snapshot — six months to 30 September 2025 (H1 FY2026)
Source: Interim Results Announcement, 26 Nov 2025; Bulletin Express via iTiger, 3 Dec 2025. Total assets HK$1.79bn, current ratio 1.89 and net gearing 19% at 30 Sep 2025. The H2 FY2026 attributable loss was therefore ~HK$76.7m, concentrated in year-end revaluations: the HK$42.2m investment-property fair-value loss and the HK$11.4m hotel revaluation deficit.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Key assets / products |
|---|---|---|
Property development and investment | Development of residential and commercial properties; holding of investment properties | Century Place Kaifeng (Sections A–G); World Expo Kaifeng; investment properties (HK$634.1m) including 53,600 sq.m. of leased shops (Section A) and a 6,200 sq.m. hotel leased to a third party (Section F) |
Trading | Trading of medical equipment, wellness and pandemic-prevention products, and home security and automation products, with installation and maintenance | Hydrotherapy pools and rehab equipment; PPP medical-grade air purifiers; video management and AI analytics (via associate Axxonsoft HK) |
Hotel operations | Operation of hotels | Holiday Inn Express Kaifeng City Center; Orange Hotel; Hi Inn Kaifeng Millennium City Park; Atour Hotel |
Revenue by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Property development and investment (HKD Mn) | 31.4 | 34.8 | 86.3 | 76.1 | 39.7 |
Trading (HKD Mn) | 69.6 | 52.2 | 28.7 | 40.3 | 42.5 |
Hotel operations / Others (HKD Mn) | 9.1 | 10.6 | 13.1 | 19.1 | 39.4 |
Total revenue (HKD Mn) | 110.0 | 97.6 | 128.1 | 135.5 | 121.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Property development and investment result (HKD Mn) | -119.0 | 36.4 | -53.2 | -27.2 | -47.0 |
Trading result (HKD Mn) | 2.9 | 6.5 | -2.8 | 2.3 | -0.2 |
Hotel operations result (HKD Mn) | -24.6 | -6.9 | -10.1 | -6.3 | -18.7 |
Total segment result (HKD Mn) | -140.6 | 35.9 | -66.1 | -31.1 | -65.8 |
Segment Margins & Growth (%)
| Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Property segment margin (%) | -379.4 | 104.4 | -61.6 | -35.7 | -118.1 |
Trading segment margin (%) | 4.2 | 12.4 | -9.7 | 5.8 | -0.4 |
Hotel segment margin (%) | -271.7 | -65.6 | -77.4 | -32.8 | -47.5 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Property revenue YoY (%) | -30.8 | 11.0 | 147.8 | -11.8 | -47.8 |
Trading revenue YoY (%) | 41.7 | -25.0 | -45.0 | 40.2 | 5.7 |
Hotel revenue YoY (%) | -3.7 | 16.8 | 23.7 | 46.1 | 106.3 |
Property share of revenue (%) | 28.5 | 35.7 | 67.4 | 56.2 | 32.7 |
Trading share of revenue (%) | 63.3 | 53.5 | 22.4 | 29.7 | 35.0 |
Hotel share of revenue (%) | 8.2 | 10.8 | 10.2 | 14.1 | 32.4 |
Revenue Lines
| Revenue line | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Sale of properties (HKD Mn) | 7.2 | 10.9 | 68.1 | 55.3 | 29.8 |
Rental income from investment properties (HKD Mn) | 24.2 | 23.9 | 18.2 | 20.8 | 9.9 |
Medical equipment, wellness and pandemic products (HKD Mn) | 57.5 | 45.3 | 24.7 | 37.5 | 40.2 |
Home security and automation (HKD Mn) | 12.1 | 6.8 | 4.0 | 2.8 | 2.3 |
Hotel operations (HKD Mn) | 9.1 | 10.6 | 13.1 | 19.1 | 39.4 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 110.0 | 97.6 | 128.1 | 135.5 | 121.7 |
Cost of sales (HKD Mn) | -58.5 | -46.9 | -85.2 | -78.0 | -67.0 |
Gross profit (HKD Mn) | 51.5 | 50.7 | 42.9 | 57.5 | 54.7 |
Other income and gains (HKD Mn) | 17.5 | 17.1 | 92.9 | 24.2 | 17.9 |
Fair value gain/(loss) on investment properties (HKD Mn) | -73.3 | 46.3 | -32.4 | -14.1 | -42.2 |
Fair value gain/(loss) on equity investments FVTPL (HKD Mn) | 110.2 | -75.7 | -104.9 | -13.7 | -7.4 |
Administrative expenses (HKD Mn) | -75.7 | -71.7 | -77.3 | -83.6 | -94.6 |
Other operating income/(expenses) net, excl. FVTPL (HKD Mn) | -70.8 | -15.6 | -29.1 | -27.9 | -10.6 |
Gain/(loss) on disposals of subsidiaries and investment properties (HKD Mn) | 0.0 | -2.1 | 72.7 | 0.0 | 0.0 |
Operating profit/(loss) before finance costs and associates (HKD Mn, derived) | -40.6 | -51.0 | -35.3 | -57.5 | -82.2 |
Finance costs (HKD Mn) | -25.2 | -36.7 | -26.4 | -18.3 | -12.1 |
Share of associates (HKD Mn) | 20.8 | 1.8 | 0.0 | -0.2 | -0.4 |
Pre-tax profit/(loss) (HKD Mn) | -45.1 | -85.9 | -61.6 | -76.0 | -94.8 |
Income tax credit/(expense) (HKD Mn) | 14.1 | -8.0 | -15.1 | 0.1 | 10.6 |
Net loss for the year (HKD Mn) | -31.0 | -93.9 | -76.8 | -75.9 | -84.2 |
Net loss attributable to owners (HKD Mn) | -27.3 | -91.0 | -75.7 | -73.7 | -82.3 |
Segment depreciation (HKD Mn) | 13.1 | 12.7 | 12.3 | 14.4 | 25.8 |
EBITDA (HKD Mn, derived: operating loss + segment depreciation) | -27.5 | -38.3 | -23.0 | -43.1 | -56.4 |
EPS basic (HK cents) | -2.42 | -6.20 | -5.16 | -5.03 | -5.61 |
EPS diluted (HK cents) | -2.42 | -6.20 | -5.16 | -5.03 | -5.61 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Company-defined core loss attributable (HKD Mn) | — | — | — | 42.1 | 44.5 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 46.8 | 52.0 | 33.5 | 42.5 | 44.9 |
Operating margin (%) | -36.9 | -52.3 | -27.6 | -42.4 | -67.5 |
EBITDA margin (%) | -25.0 | -39.3 | -18.0 | -31.8 | -46.3 |
Pre-tax margin (%) | -41.0 | -88.1 | -48.1 | -56.1 | -77.9 |
Net margin (%) | -28.2 | -96.3 | -59.9 | -56.0 | -69.2 |
Admin expenses / revenue (%) | 68.9 | 73.5 | 60.4 | 61.7 | 77.7 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 2,469.8 | 2,262.8 | 1,978.8 | 1,742.1 | 1,577.7 |
Investment properties (HKD Mn) | 1,011.1 | 684.1 | 661.9 | 641.6 | 634.1 |
Property plant and equipment (HKD Mn) | 306.2 | 282.5 | 253.8 | 306.2 | 455.4 |
Properties held for sale (HKD Mn) | 784.7 | 702.1 | 581.0 | 459.3 | 299.1 |
Equity investments at FVTPL (HKD Mn) | 229.8 | 157.5 | 39.8 | 28.1 | 22.1 |
Assets held for sale – Haikou disposal group (HKD Mn) | 0.0 | 332.2 | 0.0 | 0.0 | 0.0 |
Cash and cash equivalents (HKD Mn) | 43.9 | 24.4 | 42.3 | 36.1 | 31.4 |
Pledged deposits (HKD Mn) | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
Short-term debt incl. bonds and related-party loans (HKD Mn) | 263.3 | 222.2 | 305.9 | 151.0 | 86.7 |
Long-term debt incl. bonds and related-party loans (HKD Mn) | 197.4 | 254.3 | 60.5 | 57.6 | 12.0 |
Total interest-bearing debt excl. leases (HKD Mn) | 460.7 | 476.5 | 366.4 | 208.6 | 98.7 |
Lease liabilities (HKD Mn) | 0.0 | 1.0 | 0.7 | 40.6 | 43.6 |
Net debt excl. leases (HKD Mn, derived) | 416.8 | 452.1 | 324.1 | 172.5 | 67.3 |
Net debt incl. leases (HKD Mn, derived) | 416.8 | 453.1 | 324.8 | 213.1 | 110.9 |
Total equity (HKD Mn) | 1,672.1 | 1,467.3 | 1,341.6 | 1,241.9 | 1,217.1 |
Equity attributable to owners (HKD Mn) | 1,677.7 | 1,477.7 | 1,353.1 | 1,255.5 | 1,232.5 |
Non-controlling interests (HKD Mn) | -5.6 | -10.5 | -11.5 | -13.6 | -15.4 |
Goodwill and intangibles (HKD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Current assets (HKD Mn) | 913.0 | 1,134.0 | 853.6 | 705.3 | 435.5 |
Current liabilities (HKD Mn) | 419.0 | 415.8 | 475.1 | 308.8 | 222.6 |
Working capital / net current assets (HKD Mn) | 494.0 | 718.2 | 378.5 | 396.6 | 213.0 |
Deferred tax liabilities (HKD Mn) | 181.3 | 124.8 | 101.2 | 95.4 | 87.5 |
NAV per share attributable (HK$, derived) | 1.14 | 1.01 | 0.92 | 0.86 | 0.84 |
Cash Flow and Key Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Capital expenditure – PP&E additions incl. right-of-use (HKD Mn) | 11.1 | 0.4 | 0.3 | 52.8 | 46.0 |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Equity raised – rights issue net (HKD Mn) | 46.7 | 0 | 0 | 0 | 0 |
Haikou disposal consideration received in cash (CNY Mn) | 0 | 0 | 0 | 120 | 110 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE – attributable loss / avg attributable equity (%) | -1.7 | -5.8 | -5.3 | -5.7 | -6.6 |
ROA – net loss / avg total assets (%) | -1.3 | -4.0 | -3.6 | -4.1 | -5.1 |
ROIC – operating loss / (equity + debt + leases), period end, pre-tax (%) | -1.9 | -2.6 | -2.1 | -3.9 | -6.0 |
Current ratio – company reported (x) | 2.18 | 2.73 | 1.80 | 2.28 | 1.96 |
Gross debt incl. leases / total equity (%) | 27.6 | 32.5 | 27.4 | 20.1 | 11.7 |
Net gearing – company reported (%) | 25 | 31 | 24 | 17 | 9 |
Interest coverage – operating profit / finance costs (x) | -1.6 | -1.4 | -1.3 | -3.1 | -6.8 |
Asset turnover – revenue / avg total assets (x) | 0.045 | 0.041 | 0.060 | 0.073 | 0.073 |
Income Statement and Margin Analysis (%)
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Revenue (HKD Mn) | 92.0 | 53.7 |
Gross profit (HKD Mn) | 30.7 | 29.2 |
Gross margin (%) | 33.4 | 54.4 |
Loss attributable to owners (HKD Mn) | -14.6 | -5.6 |
Loss per share (HK cents) | -1.00 | -0.38 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Region and Revenue by Region (%)
| Region | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Hong Kong revenue (HKD Mn) | 58.6 | 45.9 | 25.1 | 37.7 | 40.4 |
Mainland China revenue (HKD Mn) | 51.4 | 51.6 | 102.9 | 97.7 | 81.2 |
Hong Kong share (%) | 53.3 | 47.1 | 19.6 | 27.9 | 33.2 |
Mainland China share (%) | 46.7 | 52.9 | 80.4 | 72.1 | 66.8 |
Hong Kong YoY growth (%) | 64.0 | -21.6 | -45.3 | 50.2 | 7.1 |
Mainland China YoY growth (%) | -24.5 | 0.4 | 99.4 | -5.1 | -16.9 |
Revenue by Region
| Segment × region | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Property sales – Mainland China (HKD Mn) | 7.2 | 10.9 | 68.1 | 55.3 | 29.8 |
Rental income – Mainland China (HKD Mn) | 24.2 | 23.9 | 18.2 | 20.8 | 9.9 |
Trading – Hong Kong (HKD Mn) | 58.6 | 45.9 | 25.1 | 37.7 | 40.4 |
Trading – Mainland China (HKD Mn) | 11.0 | 6.2 | 3.6 | 2.5 | 2.1 |
Hotels – Mainland China (HKD Mn) | 9.1 | 10.6 | 13.1 | 19.1 | 39.4 |
Region Assets & Liabilities
| Region | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Hong Kong non-current assets (HKD Mn) | 138.6 | 139.2 | 127.1 | 103.6 | 97.5 |
Mainland China non-current assets (HKD Mn) | 1,178.7 | 827.4 | 952.6 | 899.5 | 1,017.7 |
Capital Markets
| Item | Value | Basis / source |
|---|---|---|
Shares outstanding | 1466.82 million | FY2026 Results Announcement |
Market capitalisation | ~HK$100–142 million | Derived; TipRanks HK$107.1m (7 Nov 2025) |
Enterprise value | HK$280.6m per TipRanks (Nov 2025). Analyst derivation at Mar-2026: market cap ~HK$100–142m + net debt including leases HK$110.9m − NCI deficit adjustment ≈ HK$211–253m | TipRanks; derived |
P/E | Not meaningful (losses) | — |
EV/EBITDA | Not meaningful (negative EBITDA) | — |
EV/Sales (FY2026) | ~1.7x–2.1x (derived on EV of HK$211–253m) | Derived |
P/B (attributable equity HK$1232.5m) | ~0.08x–0.12x | Derived |
Average daily volume | ~547,841 shares (TipRanks, Aug 2025) | TipRanks |
Analyst coverage | 0 analysts | Simply Wall St |
Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Shares outstanding year end (M) | 1,466.8 | 1,466.8 | 1,466.8 | 1,466.8 | 1,466.8 |
Debt Maturity Profile
| Maturity bucket | Bank and other borrowings | Lease liabilities | Bonds | Total |
|---|---|---|---|---|
Within 1 year | 86.7 | 5.1 | 0.0 | 91.8 |
Beyond 1 year | 12.0 | 38.5 | 0.0 | 50.5 |
Total | 98.7 | 43.6 | 0.0 | 142.3 |
Capital Markets Data and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross debt excl. leases (HKD Mn) | 460.7 | 476.5 | 366.4 | 208.6 | 98.7 |
Cash and equivalents (HKD Mn) | 43.9 | 24.4 | 42.3 | 36.1 | 31.4 |
Net gearing – company (%) | 25 | 31 | 24 | 17 | 9 |
Finance costs (HKD Mn) | 25.2 | 36.7 | 26.4 | 18.3 | 12.1 |
Analyst Conclusions
Management guidance
There is no quantitative guidance. The qualitative outlook from the FY2026 Results Announcement has four parts:
-
Kaifeng property is a prolonged buyer's market, with returns likely limited for 1–2 years.
-
The hotels outlook is stable but faces cost and staffing headwinds; management will pursue service upgrades and cost control.
-
Hong Kong rehabilitation and hydrotherapy demand is expected to be steady and resilient in 2026.
-
Security and automation will push AI analytics and smart-city solutions through Axxonsoft HK.
Consensus
None. There is zero sell-side coverage, so no consensus revenue or earnings estimates exist.
Bull case (grounded in the data)
-
Hotel run-rate inflection. FY2026 hotel revenue (HK$39.4m) includes only about 10 months of Hi Inn and 7 months of Atour. Annualising those two hotels at FY2026 run-rates implies roughly HK$4m and HK$15m of revenue respectively, versus HK$3.4m and HK$8.8m booked (analyst arithmetic, assuming stable occupancy). That would lift segment revenue to about HK$47–50m in FY2027, and depreciation is largely fixed.
-
Balance-sheet repair largely done. Net gearing of 9% and finance costs down 67% from FY2023 mean the remaining value erosion is operational, not financial. Management's core loss excluding hotel fit-out depreciation fell to HK$25.8m from HK$35.3m.
-
Extreme discount to NAV. At ~0.1x P/B against HK$634m of investment properties and HK$455m of PP&E (largely hotels), even a 50% haircut to book NAV implies a multiple of the market value. Any monetisation (asset sale, re-tenanting Section A, or a controlling-shareholder privatisation) could be strongly accretive.
Bear case (grounded in the data)
-
NAV is not real if it keeps shrinking. Attributable equity fell from HK$1.68bn to HK$1.23bn in four years (−27%). Year-end revaluations keep producing losses (−HK$42.2m investment property and −HK$11.4m hotels in FY2026), and Kaifeng fundamentals are still deteriorating on management's own description.
-
Structural overhead and owner-operator economics. Administrative expenses (HK$94.6m) exceed group gross profit. The hotel segment lost HK$18.7m even after doubling revenue, and franchise fees plus fixed lease and depreciation costs cap margins.
-
Liquidity is tightening as the Haikou cash runs out. Only RMB15m of disposal receivables remain, cash is HK$31.4m against HK$86.7m of short-term debt, and there is no dividend capacity. Further losses may require asset-backed refinancing or equity issuance; the 20% general mandate is available, and the last rights issue was priced at HK$0.10.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | What to watch |
|---|---|---|
| Late Nov 2026 | H1 FY2027 interim results | First half with all four hotels open; hotel segment profitability; Kaifeng sales area; rental re-tenanting |
| Ongoing | Kaifeng tourism data and hotel RevPAR | Whether Orange and Atour sustain 80–90% occupancy; Holiday Inn repositioning |
| By 30 Jun 2027 | Final Haikou instalment (RMB15m outstanding) | Collection on schedule |
| FY2027 | Refinancing of HK$86.7m of current borrowings | Terms, collateral, any related-party funding |
| FY2027 | Section A re-tenanting (53,600 sq.m.) | Recovery of rental income lost to the mall lease termination |
| FY2027 | Further hotel conversions (Section G inventory) | Capex vs incremental RevPAR |
| Mar 2027 | Year-end investment-property and hotel revaluations | Magnitude of further fair-value losses |
| Ongoing | RMB/HKD exchange rate | Translation impact on NAV |
| Ongoing | Hong Kong Hospital Authority tenders and payments | Trading backlog and receivable quality |
| Ongoing | Corporate action by the controlling shareholder | Any privatisation, asset injection or disposal |
Analyst verdict
Deson Development is best understood not as a property developer but as a small, controlled, deep-discount asset vehicle in the middle of a strategic conversion. Over five years management has executed the defensive part of its plan competently. It exited Hainan at RMB385m and collected almost all of the consideration. It unwound volatile equity investments, and it cut gross debt by roughly 80%, taking net gearing from 31% to 9%. It has also found a credible use for unsellable Kaifeng inventory: three new branded hotels in the Song City tourist zone are running at 79–91% occupancy, and hotel revenue doubled to HK$39.4m.
The offensive part, turning these assets into profits, has not yet happened. The group has lost money every year in the review period. Overhead exceeds gross profit, and year-end revaluations of Kaifeng property keep eroding book value by roughly HK$50–100m a year in total. Rental income halved when a large mall tenant left, and property sales are drying up in a market management itself calls a prolonged buyer's market.
The shares, at roughly 0.1x book, already price in substantial further erosion. The equity therefore behaves like a long-dated option on three things: Kaifeng tourism sustaining hotel economics; re-tenanting or selling the HK$634m investment-property book at prices not far below carrying value; and eventual corporate action by the 44.6% controlling shareholder. Liquidity is the near-term constraint, with HK$31m of cash against HK$87m of short-term borrowings and the Haikou receivable nearly exhausted. Governance concentration, zero coverage and thin trading volumes limit institutional suitability.
Verdict: speculative special situation, not investable for most institutional mandates. Positive momentum in the hotel segment is real but too small to offset structural overhead and continuing asset write-downs. A re-rating requires evidence, ideally in the November 2026 interim results, that the hotel segment turns profitable at the pre-tax level and that year-end revaluation losses moderate. Until then, the discount to NAV is likely to persist.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / background | FY2026 total compensation |
|---|---|---|---|
Mr. Tjia Boen Sien (謝文盛) | Managing Director and Chairman; Executive Director; Remuneration and Nomination Committee member; authorised representative | Long-serving leader (Managing Director and Deputy Chairman by 2012; later Chairman). Controlling shareholder (~44.58%). Historically also a director-level shareholder in the spun-off Deson Construction (8268). | Not publicly disclosed in reviewed sources (in the FY2026 annual report emoluments note) |
Mr. Wang Jing Ning (王京寧) | Executive Director; Remuneration and Nomination Committee member | Long-standing executive; bought 15% of Treasury Field from the group (Sep 2024) | Not publicly disclosed in reviewed sources |
Mr. Tjia Wai Yip, William (謝偉業) | Executive Director | — | Not publicly disclosed in reviewed sources |
Ms. Tse Hoi Ying (謝凱盈) | Executive Director; director of medical-equipment subsidiaries | Oversees the medical-equipment trading subsidiaries | Not publicly disclosed in reviewed sources |
Ir Siu Man Po | Independent Non-Executive Director; Audit Committee member | INED since at least FY2022 | — |
Mr. Siu Kam Chau | Independent Non-Executive Director; Chairman of Audit Committee; Chairman of Remuneration Committee (per moomoo) | INED since at least FY2022 | — |
Mr. Song Sio Chong | Independent Non-Executive Director; Audit Committee member | Joined between June 2022 and June 2024 | — |
“—” = not publicly disclosed.
Governance Overview
| Attribute | Status |
|---|---|
Board size | 7 (4 executive, 3 INEDs) |
Independence | 3/7 = 43%. This meets the Listing Rules minimum of one-third. The FY2024 board had 4 INEDs out of 8, and the FY2026 governance statement still refers to four INEDs, which appears to be legacy text from before Dr. Ho's departure (inconsistency flagged). |
Chair/CEO separation | No. Deviation from CG Code C.2.1: Mr. Tjia holds both Chairman and Managing Director roles |
Committees | Audit (3 INEDs, chaired by Siu Kam Chau); Remuneration; Nomination |
Gender diversity | 1 female director of 7 (14%) |
Family and control concentration | Chairman holds ~44.58%; at least one other executive director appears related to him |
Related-party dealings | Office lease to the Chairman's company (HK$168k p.a., de minimis); FY2025 sale of 30% of Treasury Field to two executive directors; FY2024 related-party loan (HK$37.8m at Mar-2024, HK$51.3m at Mar-2023); HK$12.3m "due to a related party" at Mar-2026 |
AGM voting | All resolutions passed unanimously at the 26 Aug 2025 AGM (TipRanks). |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Between Jun 2022 and Jun 2024 | Mr. Song Sio Chong appointed INED and audit committee member | Board expanded to 4 INEDs |
Between Jun 2024 and Jun 2026 | Dr. Ho Chung Tai, Raymond ceased to be INED; Ir Siu Man Po replaced him on the audit committee | — |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
Mr. Tjia Boen Sien (aggregate interest, direct and through controlled corporations) | ~44.58% | FY2026 Results Announcement |
Other substantial shareholders (>5%) | Not publicly disclosed in reviewed sources (see HKEX Disclosure of Interests register) | — |
Institutional holders (top 10) | Not publicly disclosed. The company has 0 analyst coverage (Simply Wall St) and institutional ownership is believed to be negligible. | — |
Free float | Approximately 55% (derived as 100% − 44.58%, before other insiders) | Derived |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Relative positioning vs Deson |
|---|---|---|---|
Kaifeng property | Central China Real Estate (HKEX: 0832) | Henan's dominant developer (Jianye brand), in debt restructuring | Far larger land bank and brand in Henan; distressed sellers depress pricing |
Kaifeng property | Zensun Enterprises (HKEX: 0185) | Zhengzhou-based Henan developer | Regional rival in Henan housing |
Kaifeng property | Local Kaifeng state-owned and private developers (unnamed) | Local developers | Compete on price in a buyer's market with high inventory |
Kaifeng hotels | — | Branded economy and midscale | Same distribution channel; Deson's lakeside villa product is differentiated |
Kaifeng hotels | — | Branded economy and midscale chains | Price competition in the Song City zone |
Kaifeng hotels | — | Branded economy chains | Same |
Kaifeng hotels | Independent heritage guesthouses and themed inns in the Song City zone | Unbranded | Compete on authenticity and price |
Hong Kong medical equipment | — | Multinational distributors | Broader catalogues and balance sheets; Deson's niche is hydrotherapy and rehab |
Hong Kong security / video analytics | Hikvision, Dahua (hardware), Milestone, Genetec (VMS) and local integrators | Global vendors and integrators | Deson is a small reseller and integrator via an associate |
HK-listed small-cap peers (valuation) | Zhicheng Development Holdings (8268; former Deson Construction) | Former sibling; construction, securities, property investment | Shares heritage and the controlling-shareholder network |
Competitor Detail
| Metric | Deson Development (0262) |
|---|---|
Latest annual revenue | HK$121.7m (FY Mar-2026) |
Revenue growth (latest) | −10.2% |
Gross margin | 44.9% |
Net margin | −69.2% |
Scale relevance | Micro-cap; 504 hotel rooms; ~30,000 sq.m. of saleable inventory |
Recent Developments
Events from Oct 2024 – Mar 2025 are included for context and marked [context].*
Not identified in the window:* litigation, regulatory sanctions, layoffs, guidance revisions (none issued), or new contract wins disclosed by separate announcement.



